This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
|
The comment(s) below were originally left at Talk:CD134/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.
Would an anti-CD134 monoclonal antibody or immunoconjugate allow for
selective destruction of RECENTLY activated T-cells ? If this is the case, presumably it could have many potential implications including Tx of graft-versus-host disease, and various new-onset T-cell mediated autoimmune diseases. Any thoughts or info ? |
Last edited at 08:33, 20 February 2007 (UTC). Substituted at 10:39, 29 April 2016 (UTC)
When I get time. - Rod57 ( talk) 12:34, 4 December 2017 (UTC)
This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||
|
The comment(s) below were originally left at Talk:CD134/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.
Would an anti-CD134 monoclonal antibody or immunoconjugate allow for
selective destruction of RECENTLY activated T-cells ? If this is the case, presumably it could have many potential implications including Tx of graft-versus-host disease, and various new-onset T-cell mediated autoimmune diseases. Any thoughts or info ? |
Last edited at 08:33, 20 February 2007 (UTC). Substituted at 10:39, 29 April 2016 (UTC)
When I get time. - Rod57 ( talk) 12:34, 4 December 2017 (UTC)